Crospon

Crospon is an endoscopic diagnostics company that is changing the face of esophageal function testing with its Endoflip® technology. These minimally invasive medical devices transform the patient experience when it comes to swallow testing and deliver a whole new diagnostic tool set into the hands of gastroenterology professionals.

Established in 2006 by chairman and chief executive John O’Dea and with offices in the US and Ireland, Crospon’s experienced team designs and manufactures medical devices that allow clinicians to assess the real-time effects of their interventions during endoscopic and laparoscopic procedures.